[Neoadjuvant chemotherapy in combined treatment of breast cancer].

Author: BavliIa L, ChepikO F, GolubevaO M, IvanovaO A, OrlovA A, SeleznevI K, SemiglazovV F, TopuzovE E

Paper Details 
Original Abstract of the Article :
The paper deals with results of complex treatment of 387 patients with stage III breast cancer assigned to either neoadjuvant chemotherapy and preoperative radiotherapy or radiation alone. A study of immediate and end results showed combination of the two modalities to be more effective than each me...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/1300803

データ提供:米国国立医学図書館(NLM)

Neoadjuvant Chemotherapy and Radiotherapy for Breast Cancer

The fight against breast cancer is a complex and multifaceted battle. This study examines the effectiveness of a combined treatment approach involving neoadjuvant chemotherapy and preoperative radiotherapy in patients with stage III breast cancer.

Combined Treatment Approach

The researchers found that this combined approach, compared to radiotherapy alone, resulted in greater tumor regression, particularly in lymph nodes. It also led to a longer period of time before the cancer recurred.

Combined Treatment Approach

This study is like a collaborative effort in the desert, where different strategies are combined to achieve a common goal. It highlights the potential benefits of combining neoadjuvant chemotherapy and preoperative radiotherapy for patients with stage III breast cancer.

Dr.Camel's Conclusion

This study is a testament to the power of collaboration and innovation in the fight against breast cancer. The combined approach offers a potentially more effective treatment option for patients with advanced disease.
Date :
  1. Date Completed 1993-05-26
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

1300803

DOI: Digital Object Identifier

1300803

Related Literature

SNS
PICO Info
in preparation
Languages

Russian

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.